Related Experiment Video
Updated: Mar 15, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
The Prevalence and Determinants of Controlled Substance Discrepancies in a Level I Trauma Hospital
Chukwuma Anyanwu1, Oliver Egwim2
1Consultant for Managed Care and Clinical Outcomes, Bizmart Pharmacy Group, Houston, TX, and was Clinical Pharmacist-QA/Anesthesiology/OR, Department of In-Patient Pharmacy, Ben Taub Hospital, Harris Health System, Houston, during this study.
Background:
Healthcare institutions are often faced with challenges and accreditation requirements for improving treatment quality, reducing waste, and avoiding diversion of drugs, particularly controlled substances. Many automated systems have replaced manual systems but may be fraught with challenges, especially when multiple users are involved.
Objective:
To describe the characteristics of controlled substance discrepancies observed in a Level I trauma hospital for Medicare.
Methods:
Discrepancy data were captured for each user involved in a transaction for a controlled substance at the Level I trauma hospital (in Ben Taub Hospital, Houston, TX), and the information was stored in a computerized database repository. Data for the 1-year study period (from January 1 through December 31, 2013) were collected for Medicare beneficiaries, using an Excel 2013 spreadsheet, and were analyzed according to basic discrepancy characteristics and descriptive statistics.
Results:
During the 12-month study period, 114,000 controlled substance discrepancies were found for 100,000 Medicare patients at this Level I trauma hospital. Vending activities accounted for the majority (52.6%) of these discrepancies. Discrepancies were most likely to occur on Wednesdays, and the medications involved most frequently were combination drugs of hydrocodone and acetaminophen.
Conclusion:
Approximately 1 (1.14) discrepancy involving a controlled substance occurred for each Medicare patient treated at the study facility. Healthcare institutions need to improve their efforts to ensure high-quality care and prevent diversion of drugs.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmaceutical Poisoning: Potential Scenarios
Drug Classes and Categories
Drug Concentrations: Measurements
Plasma...
Drug Toxicity: Risk factors
Drug Control Governance: Regulatory Bodies and Their Impact

